News
05-05-2011, 03:51 AM
Two multi-gene tests designed to predict the risk of disease progression and response to chemotherapy in breast cancer produce broadly similar results for high- and low-risk patients, but do not always agree in their predictions for those at intermediate risk, a new analysis shows.
More... (http://www.news-medical.net/news/20110505/Two-breast-cancer-genomic-tests-produce-broadly-similar-results-for-high-and-low-risk-patients.aspx)
More... (http://www.news-medical.net/news/20110505/Two-breast-cancer-genomic-tests-produce-broadly-similar-results-for-high-and-low-risk-patients.aspx)